Related Experiment Video

Updated: Jul 29, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.5K

Racial, Ethnic, and Gender Disparities in Valvular Heart Failure Management

Onyedika Ilonze1, Kendall Free2, Alexander Shinnerl3

  • 1Division of Cardiovascular Medicine, Krannert Cardiovascular Research Center, Indiana University, 1800 North Capitol Avenue, Indianapolis, IN 46202, USA.

Heart Failure Clinics
|May 25, 2023
PubMed

Insights

Racial and ethnic disparities affect valvular heart disease diagnosis and treatment, impacting heart failure outcomes. Addressing these inequities is crucial for equitable care and improved patient health.

Area of Science:

  • Cardiology
  • Public Health
  • Health Disparities

Background:

  • Valvular heart disease (VHD) diagnosis and management exhibit significant racial, ethnic, and gender disparities.
  • Equitable diagnostic evaluations are lacking, obscuring the true prevalence of VHD across diverse populations.
  • Evidence-based treatments for VHD are not delivered equitably, leading to poorer outcomes.

Purpose of the Study:

  • To examine the epidemiology of valvular heart diseases (VHD) linked to heart failure (HF).
  • To highlight disparities in the diagnosis and treatment of VHD among different racial, ethnic, and gender groups.
  • To propose strategies for improving the delivery of nonpharmacological and pharmacological treatments for VHD.

Main Methods:

  • Review of epidemiological data on VHD prevalence across demographic groups.
  • Analysis of treatment patterns and access to care for VHD.
  • Focus on disparities in heart failure management related to VHD.

Main Results:

  • VHD prevalence differs by race, ethnicity, and gender, but diagnostic access is unequal.
  • Treatment delivery for VHD is inequitable, contributing to health disparities.
  • Specific focus on disparities in nonpharmacological and pharmacological VHD treatments.

Conclusions:

  • Significant racial, ethnic, and gender disparities exist in VHD diagnosis and management.
  • Unequal access to diagnostics and treatments exacerbates VHD-related heart failure.
  • Improving equitable delivery of care is essential to reduce VHD disparities.

Keywords:
Aortic stenosisDisparitiesHeart failureMitral regurgitationRacial disparitiesSocial determinants of healthValvular heart diseaseWomen’s health

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.1K

Related Concept Videos

Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
16
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
16
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
27
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
14
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
51